Julie Gonneaud1, Eider M Arenaza-Urquijo2, Marine Fouquet2, Audrey Perrotin2, Sabine Fradin2, Vincent de La Sayette2, Francis Eustache2, Gaël Chételat2. 1. From INSERM (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.), U1077; Université de Caen Normandie, UMR-S1077 (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.) and Ecole Pratique des Hautes Etudes, UMR-S1077 (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.); and CHU de Caen, U1077 (J.G., E.M.A.-U., M.F., A.P., F.E., G.C.), Service de Biochimie (S.F.), and Service de Neurologie (V.d.L.S.), France. gonneaud@cyceron.fr. 2. From INSERM (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.), U1077; Université de Caen Normandie, UMR-S1077 (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.) and Ecole Pratique des Hautes Etudes, UMR-S1077 (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.); and CHU de Caen, U1077 (J.G., E.M.A.-U., M.F., A.P., F.E., G.C.), Service de Biochimie (S.F.), and Service de Neurologie (V.d.L.S.), France.
Abstract
OBJECTIVE: To provide a comprehensive understanding of APOE ε4 effects across the lifespan on the 3 main neuroimaging biomarkers. METHODS: Two hundred seven community-dwelling, cognitively normal APOE ε4 carriers and noncarriers aged 20-87 years were involved in this study. They underwent structural MRI, fluorodeoxyglucose-PET, and florbetapir-PET scans. The effects of APOE, age, and APOE × age interaction were assessed voxel-wise for each modality. RESULTS: There was no significant effect of APOE or APOE × age interaction on gray matter volume and glucose metabolism, although decreases with age tended to be stronger in noncarriers than in carriers. In contrast, β-amyloid (Aβ) deposition was significantly higher in carriers compared with noncarriers in a largely distributed network, and there was a significant APOE × age interaction such that Aβ deposition increased nonlinearly with age in APOE ε4 carriers only. CONCLUSIONS: Our findings highlight a differential effect of APOE ε4 on amyloid vs neurodegeneration biomarkers. APOE ε4 mainly influences Aβ deposition, while the effects on gray matter volume and glucose metabolism are at best subtle. CLINICALTRIALSGOV IDENTIFIER: NCT01638949.
OBJECTIVE: To provide a comprehensive understanding of APOE ε4 effects across the lifespan on the 3 main neuroimaging biomarkers. METHODS: Two hundred seven community-dwelling, cognitively normal APOE ε4 carriers and noncarriers aged 20-87 years were involved in this study. They underwent structural MRI, fluorodeoxyglucose-PET, and florbetapir-PET scans. The effects of APOE, age, and APOE × age interaction were assessed voxel-wise for each modality. RESULTS: There was no significant effect of APOE or APOE × age interaction on gray matter volume and glucose metabolism, although decreases with age tended to be stronger in noncarriers than in carriers. In contrast, β-amyloid (Aβ) deposition was significantly higher in carriers compared with noncarriers in a largely distributed network, and there was a significant APOE × age interaction such that Aβ deposition increased nonlinearly with age in APOE ε4 carriers only. CONCLUSIONS: Our findings highlight a differential effect of APOE ε4 on amyloid vs neurodegeneration biomarkers. APOE ε4 mainly influences Aβ deposition, while the effects on gray matter volume and glucose metabolism are at best subtle. CLINICALTRIALSGOV IDENTIFIER: NCT01638949.
Authors: Holden C Williams; Brandon C Farmer; Margaret A Piron; Adeline E Walsh; Ronald C Bruntz; Matthew S Gentry; Ramon C Sun; Lance A Johnson Journal: Neurobiol Dis Date: 2020-01-11 Impact factor: 5.996
Authors: Nicholas M Vogt; Jack F V Hunt; Nagesh Adluru; Yue Ma; Carol A Van Hulle; Douglas C Dean Iii; Steven R Kecskemeti; Nathaniel A Chin; Cynthia M Carlsson; Sanjay Asthana; Sterling C Johnson; Gwendlyn Kollmorgen; Richard Batrla; Norbert Wild; Katharina Buck; Henrik Zetterberg; Andrew L Alexander; Kaj Blennow; Barbara B Bendlin Journal: Alzheimers Dement Date: 2021-05-13 Impact factor: 16.655
Authors: Michel J Grothe; Jorge Sepulcre; Gabriel Gonzalez-Escamilla; Irina Jelistratova; Michael Schöll; Oskar Hansson; Stefan J Teipel Journal: Brain Date: 2018-09-01 Impact factor: 13.501